Trials / Conditions / Succinate Dehydrogenase Deficient Renal Cell Carcinoma
Succinate Dehydrogenase Deficient Renal Cell Carcinoma
3 registered clinical trials studyying Succinate Dehydrogenase Deficient Renal Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Bi NCT04623502 | University of Texas Southwestern Medical Center | N/A |
| Completed | Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma NCT04068831 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma NCT03635892 | Memorial Sloan Kettering Cancer Center | Phase 2 |